Click Here for 5% Off Your First Aladdin Purchase!

MBX-2982 - ≥98%, high purity , Glucose-dependent insulinotropic receptor agonist, CAS No.1037792-44-1, Glucose-dependent insulinotropic receptor agonist

  • Moligand™
  • ≥98%
Item Number
M127623
Grouped product items
SKUSizeAvailabilityPrice Qty
M127623-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$278.90
M127623-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$470.90
M127623-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,059.90
M127623-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,611.90
View related series
GPR119 Agonist

Basic Description

SynonymsMBX-2982|1037792-44-1|4-((4-(1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole|MBX2982|2-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]thiazole|B5TRY67L51|CHEMBL3260505|2-[1-(5-ethylpyrimidi
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsMBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate th
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionGlucose-dependent insulinotropic receptor agonist
Note卖完停产,不再备货
Product Description

MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.

Product Properties

ALogP3.6

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2D6 Tclin Cytochrome P450 2D6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C19 Tchem Cytochrome P450 2C19 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2A6 Tchem Cytochrome P450 2A6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GPR119 Tclin Glucose-dependent insulinotropic receptor 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]-1,3-thiazole
INCHI InChI=1S/C22H24N8OS/c1-2-16-11-23-22(24-12-16)29-9-7-17(8-10-29)21-26-18(14-32-21)13-31-20-5-3-19(4-6-20)30-15-25-27-28-30/h3-6,11-12,14-15,17H,2,7-10,13H2,1H3
InChi Key NFTMKHWBOINJGM-UHFFFAOYSA-N
Canonical SMILES CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5
Isomeric SMILES CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5
PubChem CID 25025505
Molecular Weight 448.54

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
L2325085Certificate of AnalysisJan 03, 2024 M127623
E1709075Certificate of AnalysisDec 09, 2022 M127623

Chemical and Physical Properties

SolubilityDMSO

Related Documents

References

1. Alper P, Azimioara M, Cow C, Mutnick D, Nikulin V, Michellys PY, Wang Z, Reding E, Paliotti M, Li J et al..  (2014)  Discovery of structurally novel, potent and orally efficacious GPR119 agonists..  Bioorg Med Chem Lett,  24  (10): (2383-7).  [PMID:24751443]
2. Spasov AA, Kosolapov VA, Babkov DA, Maika OY.  (2017)  Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase..  Bull Exp Biol Med,  163  (5): (695-698).  [PMID:28944428]

Solution Calculators